by USER_1 | Jun 2, 2022 | Press
Alternative purification strategy enables platform resin use across a multitude of products. Halle/Saale, Germany, June 2nd, 2022. Navigo Proteins GmbH (“Navigo”), a premier protein engineering company and developer of affinity ligands for custom chromatography...
by USER_1 | Feb 1, 2022 | Press
Halle/Saale, Germany, February 1st, 2022 – Navigo Proteins, a premier protein engineering company developing novel scaffold protein-based affinity ligands called Affilin® molecules from its Precision Targeting Toolbox, today announces the appointment of Chris-Carol...
by USER_1 | Dec 2, 2021 | Press
Companies will work toward accessing a novel strategy for breaking the tumor micronenvironment by combining ITM’s high-quality radioisotopes with Navigo’s precise target-specific affinity ligands against the fibroblast activation protein (FAP)...
by USER_1 | Sep 9, 2021 | Press
WALTHAM, MA, September 9, 2021 — Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, and Navigo Proteins GmbH (“Navigo”), today announced they have completed development and validation of a novel protein A...
by USER_1 | May 11, 2021 | Press
Solid tumor-specific scaffold protein ligands from Navigo combined with MDimune’s BioDrone® technology to create novel targeted extracellular vesicle-based therapeutics Halle/Saale, Germany and Seoul, Korea, May 11th, 2021. Navigo Proteins, a protein engineering...
Recent Comments